Radium-223 for the treatment of patients with castration-resistant prostate cancer with bone metastases

The development of resistance to endocrine therapy and the tumor progression in patients with prostate cancer are associated with an unfavourable prognosis. The article presents a review of clinical trials of efficacy and safety, as well as the experience in using radioisotope radium-223 chloride in...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: A. D. Kaprin, A. A. Kostin, N. V. Vorobyev, S. V. Popov
Formaat: Artigo
Taal:Russo
Gepubliceerd in: Remedium Group LLC 2018-07-01
Reeks:Медицинский совет
Onderwerpen:
prostate cancer
castration resistance
bone metastases
radium-223
efficacy
safety
clinical practice
Online toegang:https://www.med-sovet.pro/jour/article/view/2536
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items